ONCAlert | 2017 San Antonio Breast Cancer Symposium

The Need to Study Tissue Biomarkers

David L. Rimm MD, PhD
Published Online: 4:28 PM, Wed December 10, 2014
David L. Rimm MD, PhD, Professor of Pathology and of Medicine (Medical Oncology), Director of Pathology Tissue Services, Director of Translational Pathology, Yale School of Medicine, discusses the need for further research into tissue biomarkers in breast cancer.

Clinical Pearls

  • Tissue biomarkers may help to determine which patients will respond to certain drugs.
  • Biologically, cancers are different. It is important to be able to determine how patients will respond to treatment.

<<< Go back to the SABCS conference page



Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.